Leptin Abnormality Leads to Metabolic Disorders

Metabolic disorders are a leading cause of public health concern in the United States. Affecting over 25 percent of the adult population, many adults experience metabolic complications in combination with other health risks, including obesity and cardiovascular disease.

As part of the health risk for many individuals, the risk of cardiovascular disease, coupled with metabolic disorders, probably poses the greatest health risks. In an effort to manage the increasing numbers of individuals with these complications, many healthcare professionals are looking to hormonal balance as a key therapeutic intervention.

Leptin is a naturally produced hormone that is commonly noted to promote feelings of satiety, and prevention of hunger sensations, and promote metabolism. When too much leptin is produced, a complication known as hyperleptinaemia occurs, and is commonly associated with the development of obesity, closely associated with leptin resistance.

When leptin resistance develops, an individual may lose the ability to control feelings of hunger, feelings of satiety and manage metabolism levels. In addition, without proper leptin control, the loss of nitric oxide release occurs which may then inhibit the body's ability to naturally lower blood pressure.

While it may sound strange in theory, it is shown that normal levels of leptin can be healthy. However, high levels of leptin result in hyperleptinaemia which then promotes the development of obesity, metabolic disorders and the development of cardiovascular disease. Therefore, finding ways in which to manage normal and healthy leptin levels may be crucial to the prevention and control over such diseases. While there is little advance in this area of health prevention today, it is expected there will be continued advances in development over the next decade, ultimately leading to a reduction in even the metabolic conditions such as insulin resistance and Type 2 diabetes.

If you, or someone you love, suffers from complications associated with obesity, cardiovascular disease or other abnormal metabolic condition, the complication may be associated with a hormonal imbalance involving leptin. Consult an endocrinologist about the use of medications to manage the disorder and stay abreast of the advances in medical research, especially that which involves reducing the complications and development of hyperleptinaemia.

With leptin, and loss of satiety as a key focus, many adults anticipate a medical discovery in this area will significantly reduce the number of individuals suffering from metabolic disorders. The timing for such discovery has not yet come but, for each metabolic syndrome diagnosed, one more person is eagerly awaiting the results and development of a drug to control hyperleptinaemia.